Tuberculosis: New Challenges in Diagnosis and Treatment

Tuberculosis (TB) remains a major global health challenge, with emerging drug resistance and co-infection with HIV complicating diagnosis and treatment. Traditional diagnostic methods, including sputum smear microscopy and culture, often lack sensitivity and can lead to delayed treatment. Advances in molecular diagnostics, such as nucleic acid amplification tests, have significantly improved TB detection rates, but implementation is hindered by cost and infrastructure limitations. The emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) presents significant obstacles, necessitating innovative treatment strategies. Co-infection with HIV further complicates TB management, requiring integrated care approaches. Future directions in TB management focus on developing novel diagnostic technologies and therapeutic agents, alongside robust global health initiatives aimed at reducing TB incidence and mortality.